Helpline
Call 1.855.378.4373 to schedule a call time with a specialist or visit scheduler.drugfree.org
Helpline
Helpline
Call 1.855.378.4373 to schedule a call time with a specialist

The Latest News from Our Field

We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.

Mental illness and substance use disorder must both be addressed in order to reduce fentanyl deaths, White House office of National Drug Control Policy Director Rahul Gupta said at a congressional hearing.
Men are almost three times as likely as women to die from alcohol-related causes than women, but the rate of alcohol-related deaths is rising faster among women, a new study finds.
The U.S. Food and Drug Administration has approved a second over-the-counter naloxone product, The Hill reports. RiVive is the first version of OTC naloxone from a non-profit company, which says it will make at least 200,000 doses available for free.
Find more of our must-reads in policy news, including the FDA's approval of a second over-the-counter naloxone spray.
View our curated digest of the latest research news, including the use of digital health technologies for opioid use disorder.
The Biden administration this week proposed a rule that would require health insurers to offer patients better access to mental health care and addiction treatment, STAT reports.
More than 10% of young adults in the United States regularly use e-cigarettes, a new government report finds.
Many U.S. health care providers are still not comfortable prescribing buprenorphine to treat opioid addiction, according to a new study.
Find more of our must-reads in policy news, including the Biden administration's proposal to strengthen parity laws.
View our curated digest of the latest research news, including an evaluation of nicotine delivery system use following the FDA's enforcement against fruit-flavored cartridges.
Most overdose deaths from cocaine or psychostimulants such as methamphetamine also involve opioids, according to a new report from the Centers for Disease Control and Prevention.
The White House Office of National Drug Control Policy announced a plan to coordinate a response against xylazine, the powerful animal sedative that is often mixed with fentanyl. The plan does not include new restrictions on xylazine, the Associated Press reports.
Since it was launched in July 2022, the 988 crisis lifeline has received almost 5 million contacts, according to a brief by KFF.
Find more of our must-reads in policy news, including the White House's new response plan to address xylazine.
View our curated digest of the latest research news, including a study on trends in opioid-related deaths during the COVID-19 pandemic.
The U.S. Food and Drug Administration is unable to control the flow of unauthorized disposable vaping products into the country from China, The Associated Press reports. The number of e-cigarette devices sold in the U.S. has almost tripled to more than 9,000 since 2020.
The number of people with substance use disorders skyrocketed to 39.5 million globally in 2021, a 45% increase over 10 years, according to a new report from the U.N. Office on Drugs and Crime.
San Francisco could become the first U.S. city to require all its pharmacies to always carry the opioid overdose antidote naloxone, according to The Associated Press.
Find more of our must-reads in policy news, including thousands of illegal flavored vapes coming to the U.S. from China.
View our curated digest of the latest research news, including evaluating longitudinal relationships between parental monitoring and substance use.
A new report from KFF Health News shows for the first time how much local governments are receiving from opioid settlements, revealing large differences among localities.
A coalition of criminal justice reform groups is urging the federal government to reconsider the Food and Drug Administration’s proposed ban on flavored tobacco products, The Hill reports. The groups warn the ban would lead to more overpolicing in communities of color.
New recommendations by an expert panel call for routine screening of adults ages 19 to 64 for anxiety disorders, CNN reports.
Find more of our must-reads in policy news, including documents made public that reveal the opioid settlement amounts paid to localities.
View our curated digest of the latest research news, including a review of multidisciplinary strategies for preventing opioid use and escalation by targeting mental health symptoms and conditions for youth at high risk.
1 6 7 8 9 10 359